Clinical trials
Phase 2 Anorexia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Eisai Inc. | 2 |
| Alberta Health services | 1 |
| Amanda Downey, MD | 1 |
| Anaborex | 1 |
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 1 |
| Bristol-Myers Squibb | 1 |
| Centocor, Inc. | 1 |
| Changhua Christian Hospital | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anorexia | 32 |
| Cachexia | 14 |
| Weight Loss | 10 |
| Anorexia Nervosa | 6 |
| Neoplasms | 6 |
| Feeding and Eating Disorders | 5 |
| Fatigue | 4 |
| Pancreatic Neoplasms | 4 |
| Obesity | 3 |
| Overweight | 3 |
Trials
Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.